Andreas Kjaer
Founder bij CURASIGHT A/S
Vermogen: 19 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Andreas Kjaer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
The Danish Academy of Technical Sciences
13
| College/University | Other Consumer Services | 13 |
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Medical Specialties | 11 | |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark.
6
| Private Company | Hospital/Nursing Management | 6 |
Minerva Imaging ApS
 Minerva Imaging ApS Miscellaneous Commercial ServicesCommercial Services Part of AK 2014 Holding ApS, Minerva Imaging ApS is a preclinical CRO. The private company is based in Copenhagen, Denmark. The Danish company was founded by Carsten Haagen Nielsen. Carsten Haagen Nielsen has been the CEO since incorporation.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andreas Kjaer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CBRAIN A/S | Packaged Software | Founder | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Director/Board Member Chief Tech/Sci/R&D Officer | |
| GENMAB A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Founder Public Communications Contact | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| MACONOMY CORP | Packaged Software | Chief Operating Officer Chief Executive Officer | |
| BIOPORTO A/S | Medical Specialties | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Danfoss A/S
 Danfoss A/S Industrial MachineryProducer Manufacturing Danfoss A/S operates as an engineering company. The firm manufactures refrigeration, air conditioning, and industrial controls for several industries. Its products include thermostatic expansion valves, solenoid, pressure and temperature regulators, electronic controls, line components, electronically operated, coils, solenoid, pressure controls and thermostats, filter driers, sight glasses, contactors and motor starters, liquid level controls, condensing units, appliance, controls accessories and spare parts, compressors for air conditioning, heating and refrigeration, heat exchangers, and valve station. It operates through the following segments: Danfoss Power Solutions, Danfoss Climate Solutions, Danfoss Power Electronics and Drives, and Other Areas. The Danfoss Power Solutions segment establishes electric powertrain systems. The Danfoss Climate Solutions segment includes heating and cooling solutions for buildings, cold chains, industry, and infrastructure. The Danfoss Power Electronic and Drives segment focuses on the decarbonization with electric and energy solutions for vehicles and industry. The company was founded by Peter Johan Mads Clausen on September 1, 1933 and is headquartered in Nordborg, Denmark. | Industrial Machinery | Chairman Director/Board Member | |
| PHARMA EQUITY GROUP A/S | Real Estate Development | Chairman Director/Board Member | |
| INSEAD | College/University | Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Doctorate Degree | |
| University of Aarhus | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Director/Board Member Masters Business Admin Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer | |
| University of Copenhagen | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Norwegian University of Science & Technology | College/University | Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Putega Holding ApS
 Putega Holding ApS Financial ConglomeratesFinance Putega Holding ApS functions as an investment holding Danish company. The private company is based in Hellerup City, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| Danmarks Farmaceutiske Universitet | College/University | Undergraduate Degree Graduate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin | |
Kirk & Thorsen Invest A/S
 Kirk & Thorsen Invest A/S Investment ManagersFinance Kirk & Thorsen Invest A/S (Kirk & Thorsen) is an independent private equity firm located in Vejle, Denmark. The firms was established in 2009 by its partners Casper Kirk Johansen and Peter Thorsen. | Investment Managers | Head-Equity Investments | |
| AROCELL AB | Medical Specialties | Founder | |
| The Norwegian Academy of Technological Sciences | Corporate Officer/Principal | ||
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
The Danish National Advanced Technology Foundation
 The Danish National Advanced Technology Foundation Financial ConglomeratesFinance The Danish National Advanced Technology Foundation promotes research and innovation by providing funds. It offers private companies and universities the funds and the framework for developing new and important technologies. The company was founded in 2005 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
| Copenhagen University Hospital | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Dansk IT | Director/Board Member | ||
InnoCC ApS
 InnoCC ApS Medical SpecialtiesHealth Technology InnoCC ApS manufactures and develops medical devices for critical care units, which measure heart and lung function non-invasively on the basis of gas exchange in the lungs. It also develops devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. The company was founded in 2014 and is headquartered in Odense, Denmark. | Medical Specialties | Chairman Chief Executive Officer | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cline Scientific AB
 Cline Scientific AB BiotechnologyHealth Technology Cline Scientific AB engages in the development and marketing of biomedical products for stem cell and cancer research. It offers nano gradient surfaces, nano surfaces, gold nanoparticles, and silver nanoparticles. The company was founded by Niklas Holmquist, Jenny Lindström, and Anders Patrik Sundh on September 26, 2011 and is headquartered in Gothenburg, Sweden. | Biotechnology | Director/Board Member | |
JGN 1 3-12-2018 ApS
 JGN 1 3-12-2018 ApS Medical SpecialtiesHealth Technology JGN 1 3-12-2018 ApS develops and manufactures medical devices. Its products include Innocor, an instrument measuring cardiac output non-invasively; and AMIS 2000 The company is headquartered in Glamsbjerg, Denmark. | Medical Specialties | Chairman Director/Board Member | |
| CYXONE AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Agricultural Commodities/Milling | Chairman Director/Board Member | |
Combigene Personal AB
 Combigene Personal AB Investment Banks/BrokersFinance Combigene Personal AB provides securities services. The private company is based in Hassleholm, Sweden. | Investment Banks/Brokers | Chairman | |
| MONSENSO A/S | Internet Software/Services | Chairman Founder | |
| Combigene Uk Ltd. | Chairman | ||
| Lactobio ApS | Director/Board Member Founder | ||
Aimvion A/S
 Aimvion A/S Pharmaceuticals: MajorHealth Technology Aimvion A/S provides services for autoimmune diseases and biotechnology. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman | |
| ROS-Therapeutics ApS | Chief Executive Officer | ||
TRT Innovations ApS
 TRT Innovations ApS BiotechnologyHealth Technology Part of Curasight A/S, TRT Innovations ApS is a research and Danish development company. The private company is based in Copenhagen, Denmark. The company was founded in 2015 by Andreas Kjær and Morten Persson. The CEO is Ulrich A. Krasilnikoff. TRT Innovations was acquired by Curasight A/S from AK 2014 Holding ApS on February 10, 2022 for $1.14 million. | Biotechnology | Chief Executive Officer Founder | |
| Ankor Consultants Ltd. | Chief Executive Officer |
Statistieken
Internationaal
| Denemarken | 35 |
| Zweden | 9 |
| Verenigde Staten | 4 |
| Noorwegen | 3 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 12 |
| Finance | 8 |
| Technology Services | 4 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 214 |
| Corporate Officer/Principal | 105 |
| Chairman | 71 |
| Chief Executive Officer | 46 |
| Independent Dir/Board Member | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Kaare Vagner Jensen | 37 |
| Ole Larsen | 32 |
| Peter Morch Eriksen | 32 |
| Jørgen Drejer | 26 |
| Morten Albrechtsen | 23 |
| Shomit Ghose | 23 |
| Mats Johan Peter Thorén | 22 |
| Arne Ferstad | 19 |
| Kirsten Drejer | 18 |
| Per Falholt | 18 |
| Henrik Kristian Moltke | 16 |
| Jakob Bardram | 15 |
| Mansoor Mirza | 15 |
| Alejandra Maria Mørk | 14 |
| Hans Hougaard Bang-Hansen | 13 |
- Beurs
- Insiders
- Andreas Kjaer
- Bedrijfsconnecties
